Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Susan F, Sonnenschein"'
Publikováno v:
Frontiers in Psychiatry, Vol 11 (2020)
Dysregulation of the dopamine system is central to many models of the pathophysiology of psychosis in schizophrenia. However, emerging evidence suggests that this dysregulation is driven by the disruption of upstream circuits that provide afferent co
Externí odkaz:
https://doaj.org/article/c7c8787f711d449c813c87ac66fa15f3
Publikováno v:
Expert Opin Ther Targets
INTRODUCTION: Antipsychotic drugs that target the dopamine system have been central to the treatment of schizophrenia, but their limitations in efficacy, tolerability, and precision necessitate improved treatment strategies. Multiple lines of researc
Autor:
Susan F. Sonnenschein, Ashley C. Parr, Bart Larsen, Finnegan J. Calabro, William Foran, Shaun M. Eack, Beatriz Luna, Deepak K. Sarpal
Publikováno v:
Journal of psychiatric research. 151
Subcortical structures play a critical role the pathophysiology and treatment of schizophrenia (SZ), yet underlying neurophysiological processes, in vivo, remain largely unexplored. Brain tissue iron, which can be measured with magnetic resonance-bas
Autor:
Ahmad Mayeli, Susan F. Sonnenschein, Victor E. Yushmanov, James D. Wilson, Annie Blazer, William Foran, Maria Perica, Finnegan J. Calabro, Beatriz Luna, Hoby P. Hetherington, Deepak K. Sarpal, Fabio Ferrarelli
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 24; Pages: 15846
Converging lines of evidence suggest that an imbalance between excitation and inhibition is present in the dorsolateral prefrontal cortex (DLPFC) of schizophrenia (SCZ). Gamma-aminobutyric-acid (GABA) and, to a lesser extent, glutamate (Glu) abnormal
Publikováno v:
Schizophr Bull
Pomaglumetad methionil (POM), a group 2 metabotropic glutamate receptor (mGluR2/3) agonist, showed promise as a novel antipsychotic in preclinical research but failed to show efficacy in clinical trials, though it has been suggested that it may be ef
Autor:
Dennis Hernaus, Susan F. Sonnenschein, Victoria Rodriguez, Jessica A. Wojtalik, Pasquale Di Carlo, Kelsey A. Bonfils, Chantel Kowalchuk, Zhuo-ya Yang, Imke Lemmers-Jansen, Robin Emsley, Musa Sami, Lindsay D. Oliver, Ellen E. Lee, Sunaina Soni, Michael L. Thomas, Abhishekh Ashok, Ali Bani-Fatemi, Ian S. Ramsay, Anna Waterreus, Ana P. Pinheiro, Michael W. Best, Marco Colizzi, Suhas Ganesh, Jerome H. Taylor, Dhruva Ithal, Oladunni Oluwoye, Dominic B. Dwyer, Maria R. Dauvermann, Emily Eisner, Min Tae M. Park, Tina Kristensen, Luis Alameda, Stefan S. du Plessis, Katie M. Lavigne, Helena Passarelli Giroud Joaquim, Sanja Kilian, Susan Berkhout, Brian O'Donoghue, Suzanne N. Avery
Publikováno v:
Alameda, L, Ashok, A, Avery, S, Bani-Fatemi, A, Berkhout, S, Best, M, Bonfils, K, Colizzi, M, Dauvermann, M, Plessis, S D, Dwyer, D, Eisner, E, Ganesh, S, Hernaus, D, Ithal, D, Kowalchuk, C, Kristensen, T, Lavigne, K, Lee, E, Lemmers-Jansen, I, O'Donoghue, B, Oliver, L, Oluwoye, O, Park, M T, Di Carlo, P, Joaquim, H P G, Pinheiro, A, Ramsay, I, Rodriguez, V, Sami, M, Soni, S, Sonnenschein, S, Taylor, J, Thomas, M, Waterreus, A, Wojtalik, J, Yang, Z, Emsley, R & Kilian, S 2020, ' The 2019 Schizophrenia International Research Society Conference, 10-14 April, Orlando, Florida : A summary of topics and trends ', Psychiatry Research, vol. 284, pp. 112672 . https://doi.org/10.1016/j.psychres.2019.112672, https://doi.org/10.1016/j.psychres.2019.112672
Alameda, L, Ashok, A, Avery, S, Bani-Fatemi, A, Berkhout, S, Best, M, Bonfils, K, Colizzi, M, Dauvermann, M, Plessis, S D, Dwyer, D, Eisner, E, Ganesh, S, Hernaus, D, Ithal, D, Kowalchuk, C, Kristensen, T, Lavigne, K, Lee, E, Lemmers-Jansen, I, O'Donoghue, B, Oliver, L, Oluwoye, O, Park, M T, Di Carlo, P, Joaquim, H P G, Pinheiro, A, Ramsay, I, Rodriguez, V, Sami, M, Soni, S, Sonnenschein, S, Taylor, J, Thomas, M, Waterreus, A, Wojtalik, J, Yang, Z, Emsley, R & Kilian, S 2020, ' The 2019 Schizophrenia International Research Society Conference, 10–14 April, Orlando, Florida : A summary of topics and trends ', Psychiatry Research, vol. 284, 112672, pp. 1-20 . https://doi.org/10.1016/j.psychres.2019.112672
Eisner, E 2019, ' The 2019 Schizophrenia International Research Society Conference, 10–14 April, Orlando, Florida: A summary of topics and trends. ', Psychiatry Research . https://doi.org/10.1016/j.psychres.2019.112672
Psychiatry Research, 284:112672. Elsevier Ireland Ltd
Psychiatry research
Psychiatry research, vol. 284, pp. 112672
Alameda, L, Ashok, A, Avery, S, Bani-Fatemi, A, Berkhout, S, Best, M, Bonfils, K, Colizzi, M, Dauvermann, M, Plessis, S D, Dwyer, D, Eisner, E, Ganesh, S, Hernaus, D, Ithal, D, Kowalchuk, C, Kristensen, T, Lavigne, K, Lee, E, Lemmers-Jansen, I, O'Donoghue, B, Oliver, L, Oluwoye, O, Park, M T, Di Carlo, P, Joaquim, H P G, Pinheiro, A, Ramsay, I, Rodriguez, V, Sami, M, Soni, S, Sonnenschein, S, Taylor, J, Thomas, M, Waterreus, A, Wojtalik, J, Yang, Z, Emsley, R & Kilian, S 2020, ' The 2019 Schizophrenia International Research Society Conference, 10–14 April, Orlando, Florida : A summary of topics and trends ', Psychiatry Research, vol. 284, 112672, pp. 1-20 . https://doi.org/10.1016/j.psychres.2019.112672
Eisner, E 2019, ' The 2019 Schizophrenia International Research Society Conference, 10–14 April, Orlando, Florida: A summary of topics and trends. ', Psychiatry Research . https://doi.org/10.1016/j.psychres.2019.112672
Psychiatry Research, 284:112672. Elsevier Ireland Ltd
Psychiatry research
Psychiatry research, vol. 284, pp. 112672
The Schizophrenia International Research Society (SIRS) recently held its first North American congress, which took place in Orlando, Florida from 10-14 April 2019. The overall theme of this year's congress was United in Progress – with the aim of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41dbb264d7d8b22a38f3e3ab99772b13
http://hdl.handle.net/11562/1009864
http://hdl.handle.net/11562/1009864
Publikováno v:
Neuropsychopharmacology. 44:572-580
Aripiprazole is an antipsychotic drug characterized by partial agonist activity at D2 receptors to normalize both hyperdopaminergic and hypodopaminergic states. Traditional D2 antagonist antipsychotic drugs have been shown previously to reduce dopami
Publikováno v:
Neuropharmacology
Current antipsychotic drugs (APDs) act on D2 receptors, and preclinical studies demonstrate that repeated D2 antagonist administration downregulates spontaneously active DA neurons by producing overexcitation-induced inactivation of firing (depolariz
Publikováno v:
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 44(3)
Aripiprazole is an antipsychotic drug characterized by partial agonist activity at D(2) receptors to normalize both hyperdopaminergic and hypodopaminergic states. Traditional D(2) antagonist antipsychotic drugs have been shown previously to reduce do
Background: Our previous studies show that withdrawal from prior D2 antagonist treatment interferes with the ability of novel target compounds to reverse the hyperresponsive state of the DA system in the methylazoxymethanol acetate (MAM) model of sch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f096e242c08e91cb5a4a880c2079293
https://europepmc.org/articles/PMC5475772/
https://europepmc.org/articles/PMC5475772/